Share information

Efficient diagnostics for better treatment decisions

Gentian is a company listed on Euronext Oslo Børs as GENT.

Latest share price development, trade volumes and other share information can be found on Euronext.

A full overview of shareholders including nominee accounts in accordance with the SRDII requirements

was last updated per 13 February 2025 and is available upon request at invest@gentian.no

Top 20 shareholders

31.01.2026

Shareholder No of Shares %
Vatne Equity AS 2 110 224 13.68 %
Kvantia AS 1 803 368 11.69 %
Carpe Diem Afseth AS 926 027 6.00 %
Norda ASA 716 099 4.64 %
Safrino AS 649 700 4.21 %
DNB Carnegie Investment Bank AB 645 421 4.18 %
Insr ASA 614 251 3.98 %
J.P. Morgan SE 600 000 3.89 %
DNB Bank ASA, Meglerkonto Innland 539 680 3.50 %
Verdipapirfondet Delphi Norge 389 572 2.53 %
Verdipapirfondet DNB Smb 315 854 2.05 %
Krefting, Johan Henrik 305 400 1.98 %
Intertrade Shipping AS 257 716 1.67 %
Lioness AS 220 000 1.43 %
Portia AS 217 220 1.41 %
Silvercoin Industries AS 213 178 1.38 %
Marstal AS 212 407 1.38 %
Sp Capital 22 AS 200 000 1.30 %
Alfaplan AS 185 000 1.20 %
T.D. Veen AS 174 598 1.13 %
Other Shareholders 4 126 635 26.76 %
Total Shares 15 422 350 100 %

Primary insiders 

Name and position of primary insiders can be found on Euronext.

Gentian Diagnostics ASA - Prospectus

ACCESS HERE

IR Contact

Njaal Kind
CFO, Gentian Diagnostics ASA
njaal.kind@gentian.com
+47 91906525